Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The United State Of America AS Presented By The Secretary Of Agriculture is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, Olayinka A Oyeyemi. The prosecution is localized within 1 distinct art unit. Olayinka A Oyeyemi is the busiest examiner, responsible for 1 busiest examiner pending action. With only 1 pending office action in the portfolio, this examiner is the primary point of contact.
Practitioners should tailor their strategy to the specific expertise of this 1 distinct examiner within the Biotechnology & Pharmaceuticals sector. The presence of 1 distinct art unit indicates that the technical subject matter is being reviewed by a single administrative group. Olayinka A Oyeyemi is the only official handling the 1 pending office action, so the legal team can dedicate all resources to addressing her specific concerns. This 1 busiest examiner pending action is the only active matter, which allows for a highly focused response. Practitioners should prepare for a direct negotiation with the 1 distinct examiner to move the Biotechnology & Pharmaceuticals application toward allowance. The success of the current filing depends on a single relationship with the assigned official, making the examiner interview a critical procedural step.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OYEYEMI, OLAYINKA A | 1 | 60.4% | +46.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18885015 | Methods and Compositions for Determining Salmonella Presence and Concentration Using PCR Primers of Varying Amplification Efficiencies | OYEYEMI, OLAYINKA A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18885015 | Methods and Compositions for Determining Salmonella Presence and Concentration Using PCR Primers of Varying Amplification Efficiencies | OYEYEMI, OLAYINKA A | — |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18885015 | Methods and Compositions for Determining Salmonella Presence and Concentration Using PCR Primers of Varying Amplification Efficiencies | OYEYEMI, OLAYINKA A | 1681 | §102§103 | Non-Final OA | — | Pending | Sep 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe United State Of America AS Presented By The Secretary Of Agriculture has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Olayinka A Oyeyemi has the most, with 1 of The United State Of America AS Presented By The Secretary Of Agriculture's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.